← back to search

Nancy E. Thomas

Roswell Park Comprehensive Cancer Center · US
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Melanoma, Medicine, Neuroblastoma RAS viral oncogene homolog, Oncology, Population, and Cancer research.
h-index
citations
1,018
works
12
NIH funding
primary concept
email

Recent publications

DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance
JCO Precision Oncology 2024cited by 6position: middledoi
Enhanced lipogenesis through Pparγ helps cavefish adapt to food scarcity
Current Biology 2022cited by 63position: middledoi
Landscape of mutations in early stage primary cutaneous melanoma: An <scp>InterMEL</scp> study
Pigment Cell & Melanoma Research 2022cited by 21position: middledoi
A risk prediction model for the development of subsequent primary melanoma in a population‐based cohort
British Journal of Dermatology 2019cited by 60position: middledoi
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort
The Lancet Child & Adolescent Health 2019cited by 19position: middledoi
A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis
Molecular Cancer Research 2018cited by 30position: middledoi
The state of melanoma: challenges and opportunities
Pigment Cell & Melanoma Research 2016cited by 128position: middledoi
Association Between<i>NRAS</i>and<i>BRAF</i>Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma
JAMA Oncology 2015cited by 191position: firstdoi
Melanoma Epidemiology and Prevention
Cancer treatment and research 2015cited by 146position: middledoi
Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study
Carcinogenesis 2015cited by 55position: middledoi
Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented Melanomas
JAMA Dermatology 2014cited by 175position: firstdoi
LKB1/STK11 Inactivation Leads to Expansion of a Prometastatic Tumor Subpopulation in Melanoma
Cancer Cell 2012cited by 124position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marianne Berwick · Roswell Park Comprehensive Cancer Center4 papers (2015–2019)Anne Kricker · University of Sydney2 papers (2015–2019)Richard P. Gallagher · University of New Mexico2 papers (2015–2015)Irene Orlow · Memorial Sloan Kettering Cancer Center2 papers (2015–2019)Colin B. Begg · University of New Mexico2 papers (2015–2019)Peter A. Kanetsky · University of Rochester Medical Center2 papers (2015–2019)David W. Ollila · University of North Carolina at Chapel Hill2 papers (2012–2019)Anne Ε. Cust · The University of Sydney2 papers (2015–2019)Bruce K. Armstrong · UNM Comprehensive Cancer Center2 papers (2015–2019)Yanding Zhao · Stanford University1 papers (2018–2018)Jessica A. Sorrentino · NeuroMetrix (United States)1 papers (2012–2012)Caro Badcock · University of Sydney1 papers (2019–2019) · 1 papers (2019–2019)Frank L. Meyskens · University of California, Irvine1 papers (2015–2015) · 1 papers (2012–2012)Alejandro Sánchez Alvarado · Stowers Institute for Medical Research1 papers (2022–2022)Terence Dwyer · Peterborough Regional College1 papers (2015–2015)Charles M. Perou · Oryzon Genomics (Spain)1 papers (2012–2012)Sarah Yoo · University of Georgia1 papers (2019–2019)Kimberly B. Monahan · Indiana University School of Medicine1 papers (2012–2012)